DG
Donna Glover
Credentials: · ·
History
Hematology and Medical Oncology
Internal Medicine
Research
Cisplatin neuropathy. Risk factors, prognosis, and protection by WR-2721
Cancer · 1988 · 209 citations
WR-2721 and high-dose cisplatin: an active combination in the treatment of metastatic melanoma
Journal of Clinical Oncology · 1987 · First of 5 authors · 195 citations
WR-2721 protects against the hematologic toxicity of cyclophosphamide: a controlled phase II trial
Journal of Clinical Oncology · 1986 · First of 5 authors · 133 citations
22 papers
5 papers · 4 as a fellow
3 papers
- BM
3 papers
- RG
3 papers
- AL
2 papers
- DT
2 papers
- DG
2 papers
Grants
- 1985–1988
Wr-2721: A Unique Chemoprotective and Hypocalcemic Agent
National Cancer Institute · R23
Contact PI · $163.8K · University of Pennsylvania